Error: Could not add to watchlist. X
+ Watchlist

AXA Framlington Biotech Fund

FRABIOI:LN
164.50
GBp
0.50
0.30%
As of 12:59 AM EDT 4/27/2017
Fund Type
Unit Trust
52Wk Range
124.10 - 175.90
1 Yr Return
17.67%
YTD Return
5.58%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
165.00
52Wk Range
124.10 - 175.90
1 Yr Return
16.03%
YTD Return
5.58%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/27/2017)
164.5
Total Assets (m GBP) (on 04/26/2017)
534.088
Inception Date
11/26/2001
Last Dividend (on 03/01/2017)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
1.95%

Top Fund Holdings

Name Position Value % of Fund
509.01 k 50.50 m 9.20
810.87 k 43.91 m 8.00
198.91 k 43.36 m 7.90
363.41 k 35.13 m 6.40
239.17 k 31.29 m 5.70
236.91 k 25.25 m 4.60
78.17 k 24.15 m 4.40
157.34 k 21.41 m 3.90
290.18 k 20.31 m 3.70
169.98 k 14.82 m 2.70
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
Address
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
Phone
44-207-374-4100